Optics
← Today's headlines

6 sources checked · Left, Center, and Right included · 35m ago

Mostly Same

Doctors stunned after promising heart drug fails major study

All headlines are identical, neutrally reporting that doctors are stunned after a promising heart drug failed a major study.

1 Left4 Center1 Right
Same story. Mostly aligned wording. Outlets across the spectrum framed this event in roughly the same way today.

MOSTLY SAME

As of September 9, 2026 at 10:00 AM, this is how Optics News reads the wording differences in this story.

What happened A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence High confidence. 6 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceHigh

6 sources across Left, Center, and Right all describe the same event.

Framing confidenceMostly same

0/99 — the outlets mostly agree on the headline takeaway.

WHAT EACH SIDE EMPHASIZED

Left / center-leftDoctors stunned after promising heart drug fails major study

The Plain Dealer Cleveland · Center-left · News report

CenterDoctors stunned after promising heart drug fails major study

The Star-Ledger (NJ.com) · Center · News report

Right / center-rightDoctors stunned after promising heart drug fails major study

Al.com (Alabama News) · Center-right · News report

SEE THE HEADLINES

Center-leftMostly Factual
The Plain Dealer ClevelandNews report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterHigh
The Star-Ledger (NJ.com)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterMostly Factual
OregonianNews report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
Center-rightMostly Factual
Al.com (Alabama News)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterMostly Factual
The Post-Standard (Syracuse)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
CenterHigh
The Grand Rapids Press (MLive)News report · Sep 9, 10:00 AM

Doctors stunned after promising heart drug fails major study

A Novartis heart drug lowered lipoprotein(a), a genetic heart risk factor, but failed to reduce heart attacks, strokes or cardiovascular deaths.

Open source
Details0/99 Wording Gap · High confidence · 6 sources
0/99 Wording GapHigh confidence6 sources · 3 bias bucketsStable · 6 sources · all three buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Sep 9, 10:00 AM: The Plain Dealer Cleveland joined the source map.

Sep 9, 10:00 AM: The Star-Ledger (NJ.com) joined the source map.

Sep 9, 10:00 AM: Oregonian joined the source map.

Sep 9, 10:00 AM: Al.com (Alabama News) joined the source map.

Now: Wording Gap is 0/99 and story health is stable · 6 sources · all three buckets · comparable news format.